Prism Analytic Technologies
Prism Analytic Technologies is revolutionizing research workflows by transforming raw documents and data into actionable insights through its AI-driven platform. Their flagship product, Knowledge Finder.ai, leverages large language models to enhance the efficiency of research processes, making it easier for users to extract valuable information from their libraries of PDFs. With a focus on deep learning and metascience, Prism aims to accelerate the pace of learning and breakthroughs in various sectors, including healthcare and academia. The company is positioned as a leader in the AI research space, providing reliable and secure technology tailored to meet the needs of diverse industries, ensuring innovation and efficiency.
Prism Analytic Technologies
Prism Analytic Technologies is revolutionizing research workflows by transforming raw documents and data into actionable insights through its AI-driven platform. Their flagship product, Knowledge Finder.ai, leverages large language models to enhance the efficiency of research processes, making it easier for users to extract valuable information from their libraries of PDFs. With a focus on deep learning and metascience, Prism aims to accelerate the pace of learning and breakthroughs in various sectors, including healthcare and academia. The company is positioned as a leader in the AI research space, providing reliable and secure technology tailored to meet the needs of diverse industries, ensuring innovation and efficiency.
TL;DR
Founded: 2020 (May)
Headquarters: Cambridge, Massachusetts, United States
Product: Knowledge Finder.ai — AI platform for extracting insights from documents/PDFs
Last disclosed funding: Pre-Seed (Jan 31, 2022)
Notable investors: Venture Lane; PharmStars
Company Overview
Problem Domain
Research knowledge management for life sciences and academia
Founded
2020
Industry
Administrative Services
Tech Stack
Funding Track Record
Round listed as Pre-Seed; amount undisclosed
Investor Signal
“Investors include Venture Lane and PharmStars”